Weedstocks Newswire Feed
VANCOUVER, Feb. 14, 2019 /CNW/ - Ascent Industries Corp. (CSE: ASNT) ("Ascent" or the "Company") announces that Mark Brown has resigned from the Company's Board of Directors. The Company thanks Mr. Brown for his substantial contributions.
About Ascent Industries Corp. The Company's operations currently include facilities in British Columbia, Canada; and in Oregon and Nevada in the United States. In Canada, Ascent (through its wholly-owned subsidiary, Agrima) is a licensed producer (currently suspended) under the Cannabis Act and Regulations, with licences to cultivate cannabis and produce cannabis extracts. In addition, the Company is a licensed dealer (currently suspended) under the Cannabis Act and Cannabis Regulations, with the ability to produce, package, sell, send, transport and distribute medically focused cannabis products in Canada to other licensed entities and internationally in jurisdictions where medical cannabis is legal. In the United States, the Company holds licences in Oregon (for processing and for distribution of cannabis to any licenced entity in the state) and in Nevada (for cultivation and for production, processing and wholesale distribution of cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary of Ascent, has submitted licence applications for a Wholesaler Dealers Licence and Controlled Drug Licence in Denmark, and applications for the approval of eight products to the Danish Medical Cannabis Pilot Program.
The Canadian Securities Exchange (the "CSE") has neither approved nor disapproved the contents of this press release. NEITHER THE CSE OR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
SOURCE Ascent Industries
Ascent Industries Corp. (CNW Group/Ascent Industries)
Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M
SMITHS FALLS, ON, Feb. 14, 2019 /CNW/ - Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or "the Company") today released its consolidated financial results for the third quarter fiscal 2019 ended December 31, 2018. All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
Third Quarter Fiscal 2019 Operational and Financial Highlights
Isodiol International Inc. Acquires CBD Naturals® Consumer Brands, Expands Consumer Package Goods Portfolio and Receives Strategic Funding to Expand U.S. Retail Footprint
The transaction includes over 15 brands, 40 brand domain names, 50 proprietary ingredient and product formulas, over 100,000 units of inventory, numerous pre-existing distribution relationships, and a comprehensive distribution and marketing strategy
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) today announced the acquisition of the CBD Naturals® beverage brands and intellectual property portfolio, including Hemp Rain, Rasa, Bliss Me, Fast CBD, and Simplex in a deal that includes additional financing from the Company’s founder, Jared Berry, to be used for guaranteed product placement in over 1,000 U.S. retail locations. The transactions include the transfer to Isodiol’s subsidiaries of substantially all of the intellectual property and inventory of Carlsbad Naturals LLC, a Wyoming limited liability company (“Carlsbad WY”), and Carlsbad Naturals LLC, a New Mexico limited liability company (“Carlsbad NM”).
“With the passage of the 2018 Farm Bill, we have seen an increased demand for novel cannabinoid products with an emphasis on beverages and skin care,” said Isodiol International, CEO, Marcos Agramont. “These transactions further expand our U.S. footprint in Consumer Packaged Goods (CPG) and position us at the front of the market on the whole, as well as in these highly competitive and highly lucrative categories.”
“CBD Naturals® is one of few brands to receive a registration mark from the USPTO in the hemp and cannabis industry and was the first trademark to ever be filed with ‘CBD’ in the name, which is evidence of its head start and innovation in the industry,” said Mr. Berry. “This deal will build on the brand equity and innovation that we’ve created by increasing distribution and consumer access to our products throughout all retail points of sale from direct-to-consumer sales to mainstream brick-and-mortar.”
The CBD Naturals® brand was established by Mr. Berry, Isodiol’s founder, prior to his sale of Iso International LLC to Isodiol in 2017. Over the next two years, Mr. Berry invested millions of dollars in further developing new technologies, ingredients, consumer products, and brands in multiple CPG categories. These efforts culminated in the CBD Naturals® intellectual property portfolio that is being acquired by Isodiol today.
Liht Cannabis Corp To Exclusively Use Agnetix Leading-Edge Lighting Technology In Its British Columbia Cultivation Facilities
SAN DIEGO, Feb. 14, 2019 /CNW/ -- Agnetix announced today that Liht Cannabis Corp. has selected the Agnetix A3 liquid-cooled LED lighting system for their British Columbia cultivation facilities.
Agnetix will provide its high-powered A3 LED lighting technology for current and future Liht projects in Canada, including the newly announced 486,000 sq ft high-tech indoor cultivation facility. This is the first organic cannabis facility of its kind, equipped with a cogeneration system as an alternative way to create power.
"Our cutting-edge facilities draw a tremendous amount of power for lighting and HVAC systems. With the Agnetix system, we expect to see an immediate cost reduction in our energy bill and a more efficient operation," said Richard Huhn, Director of Liht. "We have also logged very positive plant-health results using these lights and we are excited to start the new grow."
"This unique, highly-efficient technology aligns perfectly with the Liht vision to deliver low-cost organic cannabis to the world," said Dr. Ihor Lys, Founder/CTO of Agnetix.
Using the Agnetix system's unparalleled power, advanced controls, and monitoring features, Liht expects to improve its yields while saving over 50% on energy costs vs. traditional systems.
CALGARY, Feb. 14, 2019 /CNW/ - Sundial Growers Inc. (Sundial) is proud to announce that it has been cleared by the Saskatchewan Liquor and Gaming Authority ("SLGA") to supply cannabis to Saskatchewan Retail and Wholesale Permit Holders. Sundial will start supplying cannabis products to retailers in the province this year.
"As part of our overarching strategy to establish our brand across Canada, we are pleased to partner with our neighbouring prairie province." said Andrew Stordeur, Chief Commercial Officer at Sundial. "Saskatchewan's route to market is unique in Canada, and we are excited to have the opportunity to make our premium cannabis brands available to our retail partners and consumers in the province."
This new approval from SLGA will allow Sundial to create direct relationships with retailers in Saskatchewan, ensuring that its products cater to consumer needs and preferences. Sundial will continue to focus on providing uninterrupted supply to its existing customers.
Sundial crafts premium quality, small-batch cannabis with its best-in-class facilities. Sundial differentiates itself from other licensed producers by growing "craft-at-scale" cannabis using purpose-built modular systems and award-winning genetics.
For more information about Sundial Growers Inc., visit www.sundialcannabis.com and follow us on Twitter @sundialcannabis and Instagram @SundialCannabis.
Isodiol International Inc. Appoints Beverage Industry Veteran, Kevin Swadish, to a Newly Created Position as Chief Revenue Officer
Mr. Swadish Will Oversee all Consumer Packaged Goods (CPG) Revenue Channels with a Special Emphasis on Expansion of the Company’s Beverage Portfolio
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF) (FSE: LB6B.F) (the “Company” or “Isodiol”) announces the appointment of beverage industry executive Kevin Swadish to the newly created C-level position of Chief Revenue Officer of Isodiol. This position will oversee the revenue strategies for all of Isodiol’s Consumer Packaged Goods (CPG) operations, including beverages, skin care and related cosmetics, and over-the-counter products.
“We are very pleased to welcome Kevin to our team at Isodiol,” said Marcos Agramont, CEO of Isodiol. “The Company has made a number of hard choices in the restructuring of its business model and staffing in recent months to embrace its core competencies, exit non-performing operations, divest non-performing assets, and adapt to a rapidly developing industry. These are all experiences that Kevin has addressed and overcome in his storied tenure in the beverage industry, and we look forward to leveraging his experiences and relationships to achieve a dominant position in emerging CPG retail opportunities.”
Mr. Swadish has served in a variety of executive leadership roles in both mass market and specialty beverage sectors throughout the United States and developed a network of relationships that include the nation’s largest distributors and retailers. He started his career with E. & J. Gallo, which is the leading wine company in the US and considered a top training ground for industry professionals1. During his 12 years with Gallo, he assumed increasing responsibilities, including sales management of the San Diego market and as Southwest Division Manager of the company’s distributors.
Subsequently, Mr. Swadish held senior management roles at various leading wine and spirits companies. He was Senior Vice President of sales and marketing for Young's Market Company, which is one of the largest beverage alcohol distributors in the United States2. Mr. Swadish also served as Chief Operating Officer of Skyy Vodka, which was one of the largest brand introductions in the history of the U.S. spirits industry. In addition to serving as an executive of established brands, Mr. Swadish ventured into entrepreneurship and successfully formed and exited various ventures.
Sunniva Estimates Over USD $55 Million Revenue in 2019 From Sunniva Branded Products in California and Secures Additional USD $4.0 Million in Purchase Orders
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Sunniva Inc. (“Sunniva”, the “Company”, “we”, “our” or “us”) (CSE:SNN) (OTCQB:SNNVF), a North American provider of cannabis products and services, is pleased to announce that they have secured an additional USD $4.0 million in purchase orders from select retail dispensaries in southern California for Sunniva branded cannabis products. This increases the total sales orders received to date to USD $11.5 million of products to be sold in the first four months of 2019. Sunniva anticipates continued growth in sales volumes in the second quarter, increasing monthly throughout the year, secured by similar types of retail purchase contracts.
In 2019, Sunniva estimates revenue of USD $55-$60 million from sales of Sunniva branded products in California manufactured in their licensed extraction facility and from purchasing compliant third-party flower from strategic relationships that is packaged, branded, distributed and sold. Sunniva estimates combined gross margin of 40% - 50% from these product lines during the ramp up stage of operations in California. These revenues do not include Full Scale Distributors, LLC, and the large-scale high technology greenhouse in California or Natural Health Services Ltd.’s clinics in Canada.
Sunniva commenced sales of flower products in January 2019 and will be unveiling three new Sunniva brands this quarter that will include numerous product categories including flower, pre-rolls, ultra-pure distillates, vape cartridges and premium concentrates. Sunniva will continue to purchase the necessary biomass inputs (flower and trim) for its brands from strategic relationships in California, leveraging their operational extraction facility and in-house distribution.
Sunniva branded product lines within its house of brands will include:
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.
Not for distribution in the U.S. or to U.S. Newswires
VANCOUVER, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. (CSE: BLIS) (OTCQB: HSTRF) (FRA: GQ4B), (“Blissco”) or the (“Company”) is a Canadian wellness cannabis brand based in British Columbia and licensed processor, producer, and distributor of premium dried cannabis and cannabis oil. The Company is pleased to announce that it has added a new Chief Technology Officer, Brand and PR Director, and Marketing Manager to its team.
These additions will help the Company accelerate its strategic priorities and establish Blissco as a national and international brand, providing innovative and quality assured, full spectrum cannabis products to the world.
“This is an exciting time for Blissco as we ship more than 85,000 cannabis units in Canada over the next seven weeks,” said Blissco CEO, Damian Kettlewell. “Blissco’s team is committed to delivering innovative, quality assured full spectrum cannabis products and providing personal and informative client care. It is vital that we have the best team to make this vision a reality.”
Blissco is pleased to announce the appointment of Robin Killeen as our Chief Technology Officer. Mr. Killeen previously spent 13 years with Great Canadian Gaming Corporation, where he served as Director of Technical Development. Great Canadian Gaming Corporation, Canada’s largest gaming company, is publicly listed with a market cap of $3 billion and 30 locations throughout Canada and Washington. He also brings significant manufacturing and logistics knowledge and experience coordinating shipments across sectors.
Vancouver, British Columbia, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Future Farm Technologies Inc. (the “Company” or “Future Farm”) (CSE: FFT) (OTCQB: FFRMF) is pleased to announce that it has entered into a new lease with Haymart, LLC to grow CBD-producing hemp on the same 100-acre parcel which the Company leased from Haymart for its inaugural 2018 season.
The new lease covers the 2019 season and will also cover the 2020 and 2021 seasons, unless either the Company or Haymart opt out. Under the terms of the lease, Haymart will also provide farming services to Future Farm. Haymart has proven to be a key contributor to the success of Future Farm Maine and the Company is grateful for the willingness of Haymart to work creatively on the economic terms of the new lease. Future Farm and Haymart are also in discussions about working together in other aspects of the rapidly expanding market for CBD-producing hemp.
Future Farm is also pleased to announce that, with the new lease in place, it has completed its 2019 license applications for the cultivation of industrial hemp for its three Maine locations, and will submit those applications in the immediate future.
“Now is the time to make the investments and secure additional licensing so that Future Farm can continue to build on our early success in Maine,” says Zachary Lapan, manager of Future Farm Maine’s cultivation and processing operations. “Haymart, the State of Maine and the farming community around us have always been very collaborative, and we will continue working with them to expand our current footprint.”
Click here to view Future Farm’s Maine harvest video: https://www.youtube.com/channel/UCVmuRol13Qm7qlMQM2Kx77g/featured
TORONTO, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House” or the “Company”) (CSE:CHV) and Abba Medix Corp. (“Abba”), CHV’s wholly owned Licensed Producer has accelerated their phenotyping program utilizing their state-of-the-art controlled grow facility in Pickering.
Growing since May 8, 2018, Abba Medix Corp. currently has 62 strains in-house. “With our main production area fully online, we have accelerated our phenotyping program and will continue to build our genetics library. The pursuit of superior genetics will never stop at Abba. Our team knows what patients and recreational consumers expect, and we intend to deliver it,” said Riley McGee, President, Abba Medix Corp.
Utilizing its exclusive partnership with a leading European seed breeder, Abba has carefully curated a library of strains offering a wide range of cannabinoid profiles. Abba will be working closely with Canada House Clinics (CHC), leveraging their 12,000 plus patients and their proprietary Knalysis Technologies patient management software.
“Canada House’s vertical integration has been designed from day one to bring evidence-based strains to patients. With Canada House Clinic’s medical professionals and diverse patient base, our proprietary software and our state-of-the-art controlled grow facility, we are positioned to become leaders in cannabis genetics. 2019 will be a pivotal year for Canada House Wellness Group Inc. as we claim our spot as leaders in the space,” said Chris Churchill Smith, CEO, Canada House.
Working closely with CHC’s highly qualified staff, Abba seeks to better serve patients and further our understanding of cannabinoid profiles and their respective applications.